“Mitral Butterfly” will be presented in one of the most prestigious meetings for structural heart innovations worldwide.

Moreover, the abstract „Mitral Butterfly: Evaluation of a novel device in porcine and human hearts“ has been accepted and will be presented at the TVT Moderated Poster Session.
It is a great scientific success and a unique opportunity to be a part of such a clinically-relevant conference in structural heart disease.

It is an honour to be actively involved in the innovation session of the TVT Structural Heart Summit in Chicago this year.